Satsuma Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Satsuma Pharmaceuticals

10/08/2021 22:18

* Satsuma Pharmaceuticals Inc  STSA.OQ  reported a quarterly
adjusted loss of 38 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 41 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Satsuma Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 38 cents​.
* The mean earnings estimate of analysts had risen by about 3.9%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Satsuma Pharmaceuticals Inc shares had fallen by 28.2% this
quarter and gained 9.8% so far this year.
* The company reported a quarterly loss of $11.83 million.
* Wall Street's median 12-month price target for Satsuma
Pharmaceuticals Inc is $15.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 09:17 p.m.  ​All
figures in US dollars unless otherwise stated